Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C17H20N2S.ClH |
| Molecular Weight | 320.88 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C
InChI
InChIKey=XXPDBLUZJRXNNZ-UHFFFAOYSA-N
InChI=1S/C17H20N2S.ClH/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19;/h4-11,13H,12H2,1-3H3;1H
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29756
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
||
|
NCI_THESAURUS |
C740
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB04070MIG
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | |||
|
8462
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | |||
|
C45907
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | |||
|
88208-28-0
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
SUPERSEDED | |||
|
R61ZEH7I1I
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | |||
|
PROMETHAZINE HYDROCHLORIDE
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | Description: A white or faintly yellowish, crystalline powder; odourless or almost odourless. Solubility: Very soluble in water; freely soluble in ethanol (~750 g/l) TS; practically insoluble in ether R. Category: Antiemetic drug. Storage: Promethazine hydrochloride should be kept in a tightly closed container, protected from light. Additional information: On prolonged exposure to air, Promethazine hydrochloride slowly oxidizes and acquires a blue colour. Even in the absence of light, it is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures. Definition: Promethazine hydrochloride contains not less than 98.5% and not more than 101.0% of C17H20N2S,HCl, calculatedwith reference to the dried substance. | ||
|
58-33-3
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | |||
|
231688
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | |||
|
1570009
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | |||
|
6014
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | |||
|
200-375-2
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | |||
|
100000091355
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | |||
|
DTXSID3021192
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | |||
|
16639-38-6
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
SUPERSEDED | |||
|
DBSALT000427
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | |||
|
R61ZEH7I1I
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | |||
|
m9171
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL643
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | |||
|
142445
Created by
admin on Fri Dec 15 15:33:17 UTC 2023 , Edited by admin on Fri Dec 15 15:33:17 UTC 2023
|
PRIMARY | RxNorm |
ACTIVE MOIETY
SUBSTANCE RECORD